Homology Medicines (FIXX) PT Lowered to $4 at Stifel on Lack of Visibility into Clinical Hold Resolution, Awaits More Specific Updates
Tweet Send to a Friend
Stifel analyst Dae Gon Ha lowered the price target on Homology Medicines (NASDAQ: FIXX) to $4.00 (from $8.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
